The European Cancer Organisation is hosting a high-level Community 365 Roundtable on personalised treatment: tailoring prevention, diagnosis, and strategies to the individual characteristics of each patient.

Rather than adopting a one-size-fits-all model, we need to optimise health outcomes by considering a person’s unique genetic makeup, environment and lifestyle. But how do we ensure this level of care reaches many more Europeans?

The upcoming roundtable will bring together leading experts, policymakers, industry partners, and patient advocates to assess the current status of personalised oncology care and identify policy recommendations to expand access across all regions and patient groups.

Participants will explore the full ecosystem required to make precision cancer medicine a standard part of care. The roundtable will also inform current efforts to create ‘Essential Requirements for Quality Cancer Care in Personalised Medicine’, helping shape a future where every patient has equitable access to innovative cancer solutions.

Please join us as we explore the latest European initiatives, cross-border collaborations, and strategies for overcoming implementation barriers - moving from isolated solutions to systemic progress.

More information on the programme and the speakers will be shared soon.